These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 38263313)
21. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease. Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865 [TBL] [Abstract][Full Text] [Related]
22. Shared Genetic Background between Parkinson's Disease and Schizophrenia: A Two-Sample Mendelian Randomization Study. Kim K; Kim S; Myung W; Shim I; Lee H; Kim B; Cho SK; Yoon J; Kim DK; Won HH Brain Sci; 2021 Aug; 11(8):. PubMed ID: 34439661 [No Abstract] [Full Text] [Related]
23. Fine-mapping of Parkinson's disease susceptibility loci identifies putative causal variants. Schilder BM; Raj T Hum Mol Genet; 2022 Mar; 31(6):888-900. PubMed ID: 34617105 [TBL] [Abstract][Full Text] [Related]
24. Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment. Morel T; Cleanthous S; Andrejack J; Barker RA; Blavat G; Brooks W; Burns P; Cano S; Gallagher C; Gosden L; Siu C; Slagle AF; Trenam K; Boroojerdi B; Ratcliffe N; Schroeder K Neurol Ther; 2022 Sep; 11(3):1319-1340. PubMed ID: 35778541 [TBL] [Abstract][Full Text] [Related]
25. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study. Rizig M; Bandres-Ciga S; Makarious MB; Ojo OO; Crea PW; Abiodun OV; Levine KS; Abubakar SA; Achoru CO; Vitale D; Adeniji OA; Agabi OP; Koretsky MJ; Agulanna U; Hall DA; Akinyemi RO; Xie T; Ali MW; Shamim EA; Ani-Osheku I; Padmanaban M; Arigbodi OM; Standaert DG; Bello AH; Dean MN; Erameh CO; Elsayed I; Farombi TH; Okunoye O; Fawale MB; Billingsley KJ; Imarhiagbe FA; Jerez PA; Iwuozo EU; Baker B; Komolafe MA; Malik L; Nwani PO; Daida K; Nwazor EO; Miano-Burkhardt A; Nyandaiti YW; Fang ZH; Obiabo YO; Kluss JH; Odeniyi OA; Hernandez DG; Odiase FE; Tayebi N; Ojini FI; Sidranksy E; Onwuegbuzie GA; D'Souza AM; Osaigbovo GO; Berhe B; Osemwegie N; Reed X; Oshinaike OO; Leonard HL; Otubogun FM; Alvarado CX; Oyakhire SI; Ozomma SI; Samuel SC; Taiwo FT; Wahab KW; Zubair YA; Iwaki H; Kim JJ; Morris HR; Hardy J; Nalls MA; Heilbron K; Norcliffe-Kaufmann L; ; ; ; ; Blauwendraat C; Houlden H; Singleton A; Okubadejo NU; Lancet Neurol; 2023 Nov; 22(11):1015-1025. PubMed ID: 37633302 [TBL] [Abstract][Full Text] [Related]
26. Mendelian Randomisation Finds No Causal Association between Urate and Parkinson's Disease Progression. Coneys R; Storm CS; Kia DA; Almramhi M; Wood NW Mov Disord; 2021 Sep; 36(9):2182-2187. PubMed ID: 34056740 [TBL] [Abstract][Full Text] [Related]
27. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; ; ; Lancet Neurol; 2019 Dec; 18(12):1091-1102. PubMed ID: 31701892 [TBL] [Abstract][Full Text] [Related]
28. Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study. Domínguez-Baleón C; Ong JS; Scherzer CR; Rentería ME; Dong X Sci Rep; 2021 Jul; 11(1):13980. PubMed ID: 34234189 [TBL] [Abstract][Full Text] [Related]
29. Causal Association between Periodontitis and Parkinson's Disease: A Bidirectional Mendelian Randomization Study. Botelho J; Machado V; Mendes JJ; Mascarenhas P Genes (Basel); 2021 May; 12(5):. PubMed ID: 34069479 [TBL] [Abstract][Full Text] [Related]
30. Causal relationships between type 1 diabetes mellitus and Alzheimer's disease and Parkinson's disease: a bidirectional two-sample Mendelian randomization study. Geng C; Meng K; Zhao B; Liu X; Tang Y Eur J Med Res; 2024 Jan; 29(1):53. PubMed ID: 38229119 [TBL] [Abstract][Full Text] [Related]
31. A genome-wide association study coupled with machine learning approaches to identify influential demographic and genomic factors underlying Parkinson's disease. Rahman MA; Liu J Front Genet; 2023; 14():1230579. PubMed ID: 37842648 [No Abstract] [Full Text] [Related]
32. Identification of Parkinson's Disease-Causing Genes via Omics Data. Cui X; Xu C; Zhang L; Wang Y Front Genet; 2021; 12():712164. PubMed ID: 34394198 [TBL] [Abstract][Full Text] [Related]
33. Associations between polyunsaturated fatty acid concentrations and Parkinson's disease: A two-sample Mendelian randomization study. Zhu X; Huang S; Kang W; Chen P; Liu J Front Aging Neurosci; 2023; 15():1123239. PubMed ID: 36909950 [TBL] [Abstract][Full Text] [Related]
34. Bidirectional relationship between olfaction and Parkinson's disease. Kim JJ; Bandres-Ciga S; Heilbron K; ; Blauwendraat C; Noyce AJ medRxiv; 2023 Oct; ():. PubMed ID: 37905151 [TBL] [Abstract][Full Text] [Related]
35. Genetic overlap analysis of endometriosis and asthma identifies shared loci implicating sex hormones and thyroid signalling pathways. Adewuyi EO; Mehta D; ; ; Nyholt DR Hum Reprod; 2022 Jan; 37(2):366-383. PubMed ID: 35472084 [TBL] [Abstract][Full Text] [Related]
36. Protective effect of antihypertensive drugs on the risk of Parkinson's disease lacks causal evidence from mendelian randomization. Jiang Z; Gu XJ; Su WM; Duan QQ; Ren YL; Li JR; Chi LY; Wang Y; Cao B; Chen YP Front Pharmacol; 2023; 14():1107248. PubMed ID: 36909159 [No Abstract] [Full Text] [Related]
37. Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach. Kusters CDJ; Paul KC; Duarte Folle A; Keener AM; Bronstein JM; Bertram L; Hansen J; Horvath S; Sinsheimer JS; Lill CM; Ritz BR Mov Disord; 2021 Oct; 36(10):2264-2272. PubMed ID: 34426982 [TBL] [Abstract][Full Text] [Related]
38. The Parkinson's Disease Mendelian Randomization Research Portal. Noyce AJ; Bandres-Ciga S; Kim J; Heilbron K; Kia D; Hemani G; Xue A; Lawlor DA; Smith GD; Duran R; Gan-Or Z; Blauwendraat C; Gibbs JR; ; Hinds DA; Yang J; Visscher P; Cuzick J; Morris H; Hardy J; Wood NW; Nalls MA; Singleton AB Mov Disord; 2019 Dec; 34(12):1864-1872. PubMed ID: 31659794 [TBL] [Abstract][Full Text] [Related]
39. Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores. Faouzi J; Couvy-Duchesne B; Bekadar S; Colliot O; Corvol JC Parkinsonism Relat Disord; 2021 May; 86():74-77. PubMed ID: 33872999 [TBL] [Abstract][Full Text] [Related]
40. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease. Kim J; Daadi EW; Oh T; Daadi ES; Daadi MM Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]